Results 81 to 90 of about 169 (167)

Malignant Pleural Effusion: Palliative Managements and Indication for Pleurodesis Based on Survival Scores

Journal of Surgical Oncology, EarlyView.
ABSTRACT Neoplastic pleural effusion is one in which malignant neoplastic cells are detected in the pleural fluid or in the parietal pleura. When secondary, it confirms disseminated neoplastic disease and suggests a reduced life expectancy and low quality of life.
Erlon de Avila Carvalho, Rachid Eduardo Noleto da Nobrega Oliveira, José Henrique Agner Ribeiro, Jefferson Luís Gross, Cezar Augusto Vendas Galhardo, Heládio Feitosa e Castro Neto, Giovana dos Santos, Reitan Ribeiro, Alexandre Ferreira Oliveira, Rodrigo Nascimento Pinheiro   +9 more
wiley   +1 more source

Avoiding early diagnosis

Journal of General and Family Medicine, EarlyView.
Takao Wakabayashi, Goh Keng Wee, Mikinosuke Ishibashi, Yoshiki Akiyama, Naoki Kanda, Tomoyuki Watanabe   +5 more
wiley   +1 more source

Prediction of Metastasis in Small Pulmonary Oligonodules Detected in Breast Cancer Patients at Baseline CT

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT It is challenging for radiologists to diagnose pulmonary metastases when they encounter only a few (n ≤ 5) small pulmonary nodules (< 10 mm) on staging CT in breast cancer patients. We conducted this study to assess clinical and imaging features related to metastasis for better risk stratification.
Huei‐Yi Tsai, Min‐Fang Chao, Tzu‐Hsueh Tsai, Shen‐Liang Shih, Fang‐Ming Chen, Ming‐Feng Hou, Ming‐Yii Huang, Jui‐Sheng Hsu   +7 more
wiley   +1 more source

Comparative Survival Analysis of Anti‐Angiogenic Agent Plus Immunochemotherapy in NSCLC Patients After Frontline EGFR‐TKI Treatment: A Retrospective Cohort Study

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Advanced‐stage EGFR‐mutated lung non‐small cell lung cancer (NSCLC) challenges current treatment paradigms, particularly after frontline EGFR‐TKI therapy failure. This study investigates the survival impact of combined anti‐angiogenic agent and immunochemotherapy (AICT) for this population.
Yi‐Tse Su, Shu‐Farn Tey, Chung‐Ta Lee, Chien‐Yu Lin, Jeng‐Shiuan Tsai, Chien‐Chung Lin, Chin‐Wei Kuo   +6 more
wiley   +1 more source

Protein glycosylation in lung cancer from a mass spectrometry perspective

Mass Spectrometry Reviews, EarlyView.
Abstract Lung cancer is a severe disease for which better diagnostic and therapeutic approaches are urgently needed. Increasing evidence implies that aberrant protein glycosylation plays a crucial role in the pathogenesis and progression of lung cancer.
Mirjam Balbisi, Simon Sugár, Lilla Turiák   +2 more
wiley   +1 more source

Recent Advancements in the Characterization of D‐Amino Acid and Isoaspartate Post‐Translational Modifications

Mass Spectrometry Reviews, EarlyView.
ABSTRACT One of the great triumphs of mass spectrometry‐based peptide and protein characterization is the characterization of their modifications as most modifications have a characteristic mass shift. What happens when the modification does not change the mass of the peptide?
Samuel Okyem, Jonathan V. Sweedler
wiley   +1 more source

Expert Consensus on the Diagnosis and Treatment of Malignant Pericardial Mesothelioma

Med Research, EarlyView.
ABSTRACT Primary malignant pericardial mesothelioma (PMPM), a rare pericardium‐derived malignancy, urgently requires standardized diagnostic and therapeutic protocols. This consensus, established by the Chinese Alliance of Research for Mesothelioma (ChARM) through the integration of evidence‐based research and multicenter clinical expertise, addresses ...
Qing Ji, Chunwei Xu, Qian Wang, Wenxian Wang, Zhenying Guo, Ziming Li, Zhengbo Song, Aijun Liu, Jinpu Yu, Wenzhao Zhong, Zhijie Wang, Wenfeng Fang, Yongchang Zhang, Jingjing Liu, Shirong Zhang, Xiuyu Cai, Anwen Liu, Ping Zhan, Hongbing Liu, Tangfeng Lv, Liyun Miao, Lingfeng Min, Gen Lin, Long Huang, Yu Chen, Jingping Yuan, Zhansheng Jiang, Feng Wang, Xingxiang Pu, Chuangzhou Rao, Dongqing Lv, Yinghua Ji, Xianbin Liang, Zongyang Yu, Xiaoyan Li, Chuanhao Tang, Chengzhi Zhou, Junping Zhang, Xuelei Ma, Hui Guo, Qian Chu, Rui Meng, Jingxun Wu, Huaiqing Xiao, Jin Zhou, Zhengfei Zhu, Hongmei Zhang, Yingshi Piao, Xiaofeng Chen, Xuewen Liu, Enyong Dai, Yu Yao, Jian Zhang, Weiwei Pan, Fei Pang, Fan Wu, Zhiying Shao, Ling Xu, Liping Wang, Jianfei Tu, Yu Zhang, Xinqing Lin, Jing Cai, Jian Feng, Jisheng Li, Xiaodong Jiao, Kainan Li, Huijing Feng, Lin Wang, Yingying Du, Binbin Song, Xuefei Shi, Wenfeng Li, Xiaomin Niu, Jianhui Huang, Yina Wang, Yue Feng, Yinbin Zhang, Pingli Sun, Hong Wang, Dongmei Yuan, Yanwen Yao, Dong Wang, Mingxiang Ye, Zhaofeng Wang, Yue Hao, Jianan Jin, Zhen Wang, Bing Wan, Donglai Lv, Shengjie Yang, Lin Shi, Bihui Li, Zhang Zhang, Zhongwu Li, Zhefeng Liu, Nong Yang, Lin Wu, Miao Li, Xiaobing Chen, Guansong Wang, Jiandong Wang, Yong Fang, Yuan Li, Yiping Zhang, Xixu Zhu, Yi Shen, Ke Wang, Shenglin Ma, Yong Song, Youcai Zhu, Yuanzhi Lu, Meiyu Fang   +112 more
wiley   +1 more source

Optimized Dynamic Network Biomarker Deciphers a High‐Resolution Heterogeneity Within Thyroid Cancer Molecular Subtypes

Med Research, EarlyView.
An optimized dynamic network biomarker approach reveals a critical transition signal and identifies three distinct molecular subtypes of differentiated thyroid cancer, each with unique global regulatory landscapes. ABSTRACT The progression of differentiated thyroid carcinoma (DTC) poses significant clinical challenges, especially in determining the ...
Haonan Zhang, Ge Zhang, Pengyuan Xu, Fengyi Yu, Liwen Li, Runzhi Huang, Pengpeng Zhang, Kaisaierjiang Kadier, Yuanyuan Wang, Qiqi Gu, Yalei Ding, Tianshu Gu, Hao Chi, Shiqian Zhang, Ruhao Wu, Yudi Xu, Shanshan Zhu, Honglin Zheng, Taiqi Zhao, Qi He, Xinguang Qiu   +20 more
wiley   +1 more source

Thorax‐encompassing multi‐modality PET/CT deep learning model for resected lung cancer prognostication: A retrospective, multicenter study

Medical Physics, EarlyView.
Abstract Background Patients with early‐stage non‐small cell lung cancer (NSCLC) typically receive surgery as their primary form of treatment. However, studies have shown that a high proportion of these patients will experience a recurrence after their resection, leading to an increased risk of death.
Jaryd R. Christie, Perrin Romine, Karen Eddy, Delphine L. Chen, Omar Daher, Mohamed Abdelrazek, Richard A. Malthaner, Mehdi Qiabi, Rahul Nayak, Paul Kinahan, Viswam S. Nair, Sarah A. Mattonen   +11 more
wiley   +1 more source

Contactless cardiac gating at 0.55T using high‐amplitude pilot tone with interference cancellation (HAPTIC)

Magnetic Resonance in Medicine, EarlyView.
Abstract Purpose To enable contactless cardiac gating at 0.55T using pilot tone (PT). Current PT methods are unable to extract weak motions, including cardiac motion, at lower B0 field strengths (<1.5T). Methods We utilize high‐amplitude pilot tone with interference cancellation, termed HAPTIC.
Bilal Tasdelen, Ecrin Yagiz, Baran R. Cinbis, Ye Tian, Krishna S. Nayak   +4 more
wiley   +1 more source